BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28330734)

  • 1. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
    Wang J; Ayano E; Maitani Y; Kanazawa H
    Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Polymer Phase Transition Behavior on Temperature-Responsive Polymer-Modified Liposomes for siRNA Transfection.
    Nagase K; Hasegawa M; Ayano E; Maitani Y; Kanazawa H
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
    Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
    Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery.
    Podesta JE; Kostarelos K
    Methods Enzymol; 2009; 464():343-54. PubMed ID: 19903563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
    Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
    Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
    Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
    Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anionic amino acid-derived cationic lipid for siRNA delivery.
    Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
    J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
    Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
    J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal siRNA delivery.
    Hughes J; Yadava P; Mesaros R
    Methods Mol Biol; 2010; 605():445-59. PubMed ID: 20072900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes.
    Vandenbroucke RE; De Smedt SC; Demeester J; Sanders NN
    Biochim Biophys Acta; 2007 Mar; 1768(3):571-9. PubMed ID: 17188643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
    Kapoor M; Burgess DJ
    Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
    Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
    Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lyophilization and freeze-thawing on the stability of siRNA-liposome complexes.
    Yadava P; Gibbs M; Castro C; Hughes JA
    AAPS PharmSciTech; 2008; 9(2):335-41. PubMed ID: 18431646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.
    Metwally AA; Blagbrough IS; Mantell JM
    Mol Pharm; 2012 Nov; 9(11):3384-95. PubMed ID: 23057412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation.
    Barichello JM; Ishida T; Kiwada H
    Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.
    Endo-Takahashi Y; Negishi Y; Kato Y; Suzuki R; Maruyama K; Aramaki Y
    Int J Pharm; 2012 Jan; 422(1-2):504-9. PubMed ID: 22119963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
    Lee S; Shim G; Kim S; Kim YB; Kim CW; Byun Y; Oh YK
    Nucleic Acid Ther; 2011 Jun; 21(3):165-72. PubMed ID: 21749293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.